首頁 > 市場調查報告書 > 製藥

動物用醫藥

市場調查報告書

商品編碼

1496273

豬保健市場 - 全球產業規模、佔有率、趨勢、機會和預測，按類型、疾病、地區和競爭細分，2019-2029F

Swine Healthcare Market - Global Industry Size, Share, Trend, Opportunity & Forecast, Segmented By Type, By Disease, By Region and Competition, 2019-2029F

出版日期: 2024年06月14日 | 出版商:

TechSci Research | 英文 183 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年全球豬保健市場價值為 28.2 億美元，預計在預測期內將強勁成長，到 2029 年複合年成長率為 8.30%。維生素在身體的發育和正常功能中發揮著至關重要的作用，可作為激素、輔酶和抗氧化劑。飲食偏好的改變、忙碌的生活方式、就業率的上升以及對與豬保健相關的健康益處的認知的提高等各種因素預計將對全球市場的成長產生積極影響。

市場概況
預測期	2025-2029
2023 年市場規模	28.2億美元
2029 年市場規模	45.1億美元
2024-2029 年複合年成長率	8.30%
成長最快的細分市場	療法
最大的市場	北美洲

由於行程繁忙，許多人難以維持均衡飲食，導致營養缺乏。因此，為了滿足日常營養和維生素需求，促進整體健康和活力，豬隻保健品的消費量顯著增加。全球不斷增加的醫療保健支出預計將推動對豬隻醫療保健的需求。已開發經濟體和發展中經濟體不斷成長的老年人口在預測期內為市場參與者提供了利潤豐厚的機會。老年人依靠 Swine Healthcare 來滿足他們的飲食需求、促進骨骼健康並支持整體福祉。

主要市場促進因素

對豬肉產品的需求不斷增加

醫療保健解決方案不斷進步的技術

增加減少抗菌藥物使用的監管壓力

主要市場挑戰

疾病爆發

監管障礙

消費者認知與永續發展需求

主要市場趨勢

日益關注預防性醫療保健

採用數位健康解決方案

細分市場洞察

類型洞察

疾病洞察

區域洞察

Global Swine Healthcare Market was valued at USD 2.82 billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 8.30% through 2029. Swine Healthcare are designed to enhance the regular diet by providing individuals with the necessary daily nutritional value. Vitamins play crucial roles in the development and proper functioning of the body, acting as hormones, coenzymes, and antioxidants. Various factors such as shifting dietary preferences, busy lifestyles, rising employment rates, and increased awareness of the health benefits associated with Swine Healthcare are expected to positively influence the global market growth.

Market Overview
Forecast Period	2025-2029
Market Size 2023	USD 2.82 Billion
Market Size 2029	USD 4.51 Billion
CAGR 2024-2029	8.30%
Fastest Growing Segment	Therapeutics
Largest Market	North America

Due to hectic schedules, many individuals struggle to maintain a balanced diet, resulting in nutrient deficiencies. Consequently, there has been a significant rise in the consumption of Swine Healthcare to fulfil daily nutrient and vitamin requirements, promoting overall health and vitality. The increasing healthcare expenditure worldwide is anticipated to drive the demand for Swine Healthcare. The growing elderly population in both developed and developing economies presents lucrative opportunities for market players in the forecast period. The senior population relies on Swine Healthcare to meet their dietary needs, promote bone health, and support overall well-being.

Key Market Drivers

Increasing Demand for Pork Products

The increasing demand for pork products is a significant driver propelling the growth of the global swine healthcare market. This demand surge is attributed to several factors, including population growth, rising disposable incomes, urbanization, and changing dietary preferences, particularly in emerging economies.

As the global population continues to expand, especially in regions such as Asia and Africa, there is a corresponding increase in the demand for protein-rich foods, with pork being a favored choice due to its affordability, versatility, and nutritional value. Urbanization and economic development lead to dietary shifts towards higher protein consumption, further fueling the demand for pork products.

The growing affluence in emerging economies translates into higher purchasing power and increased consumption of animal protein, including pork. This trend is particularly pronounced in countries experiencing rapid urbanization and transitioning dietary patterns, where pork is often considered a staple protein source in traditional cuisines.

The versatility of pork makes it a popular choice across diverse culinary cultures, contributing to its widespread consumption globally. From traditional dishes to modern cuisines, pork products feature prominently in a wide range of culinary applications, driving sustained demand in both domestic and international markets.

As the demand for pork products continues to rise, swine producers face the challenge of meeting consumer expectations for safe, high-quality pork while ensuring the health and welfare of their livestock. This underscores the importance of investing in swine healthcare solutions to prevent diseases, enhance productivity, and meet the growing demand for pork products in a competitive global market.

Rising Technological Advancements in Healthcare Solutions

Technological advancements in healthcare solutions are playing a pivotal role in driving the growth of the global swine healthcare market. These advancements encompass a wide range of innovations, including diagnostic tools, treatment modalities, digital health technologies, and precision farming solutions, all aimed at improving swine health, productivity, and welfare.

One of the key areas of technological innovation in swine healthcare is in disease diagnostics. Advanced diagnostic tools, such as polymerase chain reaction (PCR) assays, enzyme-linked immunosorbent assays (ELISA), and next-generation sequencing (NGS) technologies, enable rapid and accurate identification of pathogens responsible for infectious diseases in swine. Early detection of diseases allows for timely intervention and targeted treatment, minimizing the spread of infections and reducing economic losses for swine producers.

Advancements in vaccine development and delivery systems have revolutionized disease prevention strategies in swine farming. Next-generation vaccines, including recombinant vaccines, vectored vaccines, and subunit vaccines, offer improved efficacy, safety, and convenience compared to traditional vaccine formulations. Novel delivery systems, such as oral vaccines and intranasal vaccines, enhance vaccine uptake and stimulate robust immune responses in swine populations, thereby reducing the incidence and severity of infectious diseases.

Digital health technologies are also driving innovation in swine healthcare by enabling real-time monitoring, data analytics, and predictive modeling capabilities. Internet of Things (IoT) devices, wearable sensors, and smart monitoring systems allow swine producers to remotely monitor key health parameters, such as body temperature, feed intake, and activity levels, facilitating early detection of health issues and proactive management interventions. Data-driven insights derived from these technologies help optimize management practices, enhance operational efficiency, and improve decision-making across the swine production chain.

Precision farming solutions harness the power of automation, robotics, and artificial intelligence (AI) to optimize resource utilization, minimize environmental impact, and maximize productivity in swine production systems. Automated feeding systems, environmental control systems, and robotic husbandry devices streamline farm operations, reduce labor costs, and ensure consistent quality standards, thereby contributing to the overall health and well-being of swine populations.

Increase in Regulatory Pressure to Reduce Antimicrobial Use

Regulatory pressure to reduce antimicrobial use is a significant driver boosting the global swine healthcare market, catalyzing innovation, and fostering adoption of alternative healthcare solutions aimed at ensuring swine health and welfare while mitigating the risk of antimicrobial resistance (AMR). This pressure stems from growing concerns over the emergence of AMR, which poses a serious threat to both animal and human health, necessitating concerted efforts to curb the overuse and misuse of antimicrobial agents in livestock production, including swine farming.

Regulatory agencies worldwide have implemented policies and guidelines to promote responsible antimicrobial use in swine production, imposing restrictions on the use of medically important antibiotics as growth promoters and advocating for prudent use practices in disease prevention and treatment. This regulatory landscape drives the need for alternative healthcare strategies that reduce reliance on antibiotics while maintaining effective disease management outcomes.

In response to regulatory pressure, swine producers are increasingly embracing preventive healthcare measures, such as vaccination programs, biosecurity protocols, and nutritional interventions, to enhance swine health and minimize the need for antimicrobial treatments. There is growing interest in alternative products and strategies, including probiotics, prebiotics, immunomodulators, and phytogenics, which promote gut health, boost immunity, and support overall swine well-being without contributing to AMR.

Advancements in diagnostic technologies enable early detection of diseases, facilitating targeted treatment interventions and reducing the necessity for broad-spectrum antimicrobial use. Rapid diagnostic tests, molecular assays, and point-of-care devices empower swine producers to make informed treatment decisions, optimize antimicrobial use, and minimize the risk of AMR emergence.

Key Market Challenges

Disease Outbreaks

One of the most significant challenges that has consistently hampered the growth of the global Swine Healthcare market is the occurrence of disease outbreaks. Swine diseases, such as African Swine Fever (ASF), Porcine Epidemic Diarrhea Virus (PEDv), and Foot-and-Mouth Disease (FMD), have wreaked havoc on swine populations across the world. These outbreaks not only lead to substantial economic losses but also threaten global food security due to reduced pork production.

The rapid spread of diseases is facilitated by factors such as global trade, travel, and inadequate biosecurity measures. The impact of these outbreaks is multi-faceted, affecting pig farmers, feed manufacturers, veterinarians, and the entire pork supply chain. The need for robust disease surveillance, early detection, and effective containment strategies is paramount to mitigate the adverse effects of disease outbreaks., ultimately impacting market growth in the forecast period.

Regulatory Hurdles

The global Swine Healthcare market operates within a complex regulatory landscape that presents significant hurdles. Regulatory frameworks vary across countries and regions, impacting disease management, genetic research, and trade practices. These regulations influence the movement of live animals, vaccines, and genetic materials, directly affecting the growth of the industry.

Navigating these regulatory hurdles requires a deep understanding of country-specific requirements, import-export regulations, and compliance standards. The time and resources spent on ensuring regulatory adherence can impede the pace of innovation and hinder the adoption of advanced technologies.

Consumer Perception and Sustainability Demands

In recent years, consumer awareness and concerns regarding animal welfare, environmental impact, and antibiotic use have grown significantly. This shift in consumer perception has led to increased demand for sustainable and ethically produced pork products. Meeting these demands while ensuring Swine Healthcare presents a unique challenge for the industry.

Striking a balance between sustainable practices, animal welfare, and efficient production requires innovative approaches. Reducing the use of antibiotics, implementing environmentally friendly waste management systems, and adopting animal-friendly housing are essential steps to address consumer demands. However, these transitions often require substantial investments, retraining of industry professionals, and changes in traditional practices.

Key Market Trends

Increasing Focus on Preventive Healthcare

The increasing focus on preventive healthcare is a significant driver propelling the growth of the global swine healthcare market. This shift in approach reflects a proactive stance aimed at preventing diseases before they occur, rather than solely relying on reactive treatment measures. Several factors contribute to the rising emphasis on preventive healthcare in the swine industry.

The intensification of swine farming practices has heightened the risk of disease outbreaks due to increased stocking densities, environmental stressors, and transmission pathways. In response, swine producers are prioritizing preventive measures to minimize the introduction and spread of pathogens within their herds. This includes implementing stringent biosecurity protocols, vaccination programs, and hygiene practices to reduce the risk of disease transmission and maintain herd health.

The emergence of antimicrobial resistance (AMR) has prompted regulatory agencies and industry stakeholders to advocate for responsible antimicrobial use in livestock production, including swine farming. As a result, there is a growing recognition of the importance of preventive healthcare strategies, such as vaccination, nutrition optimization, and environmental management, in reducing the reliance on antibiotics and preserving their effectiveness for therapeutic use.

The economic implications of disease outbreaks in swine populations underscore the importance of investing in preventive healthcare measures. Disease outbreaks can result in significant production losses, including decreased growth rates, reduced feed conversion efficiency, and increased mortality rates, leading to financial strain for swine producers. By prioritizing preventive healthcare, producers can mitigate the risk of disease-related losses and optimize the profitability and sustainability of their operations.

Advancements in diagnostic technologies enable early detection of diseases and proactive management interventions, further driving the adoption of preventive healthcare practices in the swine industry. Real-time monitoring systems, rapid diagnostic tests, and data analytics tools empower producers to identify health issues before they escalate, allowing for timely intervention and optimized treatment protocols.

Adoption of Digital Health Solutions

The adoption of digital health solutions is playing a pivotal role in driving growth in the global swine healthcare market, revolutionizing the way swine producers monitor, manage, and optimize the health and productivity of their livestock. Digital health solutions encompass a wide range of technologies, including IoT-enabled devices, wearable sensors, data analytics platforms, and precision farming systems, all aimed at enhancing efficiency, sustainability, and profitability in swine production.

One of the key drivers of the adoption of digital health solutions is the need for real-time monitoring and early detection of health issues in swine populations. IoT-enabled devices and wearable sensors allow swine producers to remotely monitor key health parameters such as body temperature, feed intake, and activity levels, providing valuable insights into the health status and well-being of individual animals and entire herds. This real-time monitoring capability enables early detection of health issues, prompt intervention, and optimized treatment protocols, ultimately improving overall herd health and productivity.

Digital health solutions enable data-driven decision-making and performance optimization across the swine production chain. Advanced data analytics platforms process and analyze large volumes of data generated from various sources, including environmental sensors, production records, and health monitoring devices, to provide actionable insights into farm operations and management practices. By leveraging these insights, swine producers can identify trends, predict outcomes, and implement targeted interventions to improve efficiency, reduce costs, and maximize profitability.

Precision farming systems represent another aspect of digital health solutions that are driving innovation in the swine healthcare market. These systems utilize automation, robotics, and artificial intelligence (AI) to optimize resource utilization, minimize environmental impact, and maximize productivity in swine production systems. Automated feeding systems, environmental control systems, and robotic husbandry devices streamline farm operations, reduce labor costs, and ensure consistent quality standards, contributing to improved efficiency and sustainability.

The adoption of digital health solutions is transforming the global swine healthcare market by enabling proactive disease management, data-driven decision-making, and precision farming practices. As swine producers recognize the value of digital technologies in optimizing health, productivity, and profitability, investment in digital health solutions is expected to continue to grow, driving innovation and market expansion in the swine healthcare sector.

Segmental Insights

Type Insights

In 2023, the therapeutics segment emerged as the dominant within the global market for Swine Healthcare. This dominance can be attributed to the increasing prevalence of diseases among swine populations worldwide, driving demand for effective treatment options. Therapeutics encompass a wide range of pharmaceutical products, including antibiotics, vaccines, antiparasitic drugs, and other medications aimed at preventing, controlling, and treating various diseases and health conditions in swine. Regulatory pressure to reduce antimicrobial use has fueled the development and adoption of alternative therapeutic strategies, such as probiotics, immunomodulators, and herbal remedies, further contributing to the growth of the therapeutics segment. As swine producers prioritize the health and welfare of their livestock, investment in therapeutic interventions remains a key focus area, driving innovation and market expansion in the global Swine Healthcare market.

Disease Insights

Based on the category of Disease, the respiratory diseases segment emerged as the dominant in the global market for Swine Healthcare in 2023. Respiratory diseases stand as a dominant force within the global Swine Healthcare market, significantly impacting swine populations, farm profitability, and the overall stability of the swine industry. These diseases, caused by a variety of pathogens, encompass conditions such as swine influenza, porcine reproductive and respiratory syndrome (PRRS), and Actinobacillus pleuropneumonia (APP), among others. The far-reaching effects of respiratory diseases underscore their prominence in the industry, making them a primary focus of attention for Swine Healthcare management. Respiratory diseases exert a heavy economic toll on the swine industry. Infected pigs experience reduced growth rates, decreased feed efficiency, and increased mortality. These factors translate into substantial financial losses for swine producers, impacting their ability to maintain profitability and invest in further production enhancements. The cost of treatments, diagnostics, and biosecurity measures adds to the economic burden associated with respiratory diseases.

Respiratory diseases often present with acute symptoms that rapidly spread among swine populations. The highly contagious nature of many respiratory pathogens, coupled with the close quarters of commercial swine facilities, facilitates rapid disease transmission. Once introduced to a farm, these diseases can quickly escalate into widespread outbreaks, causing a surge in morbidity and mortality rates.

Regional Insights

North America emerges as a dominating force in the global Swine Healthcare market, driven by its advanced agricultural practices, robust infrastructure, and well-established veterinary healthcare systems. Countries such as the United States and Canada are at the forefront of swine production and health management, contributing significantly to the market's growth and innovation. North America boasts cutting-edge technologies in disease diagnostics, genetic selection, and disease management. Advanced diagnostic tools, such as molecular tests and PCR assays, enable rapid and accurate disease detection, allowing for swift intervention. The region's strong research and development efforts drive innovation in Swine Healthcare management. Collaborations between universities, research institutions, and industry stakeholders lead to breakthroughs in disease prevention, treatment, and genetics. The presence of experienced veterinarians, swine producers, and industry experts contributes to effective disease control strategies and knowledge dissemination. This places a strong emphasis on biosecurity measures, limiting the spread of diseases and ensuring the health of swine populations.

Key Market Players

Boehringer Ingelheim International GmbH

Ceva Sante Animale

Elanco Animal Health Incorporated

Innovative Diagnostics

Merck KgaA

Vetoquinol SA

Virbac S.A.

Zoetis Inc.

IDEXX Laboratories, Inc

Phibro Animal Health Corporation

Report Scope:

In this report, the Global Swine Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Swine Healthcare Market, By Type:

Diagnostics Therapeutics

Swine Healthcare Market, By Disease:

Exudative dermatitis Coccidiosis Respiratory diseases Swine dysentery Porcine parvovirus Other

Swine Healthcare Market, By Region:

North America

United States

Canada

Mexico

Europe

France

United Kingdom

Italy

Germany

Spain

Asia-Pacific

China

India

Japan

Australia

South Korea

South America

Brazil

Argentina

Colombia

Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Swine Healthcare Market.

Available Customizations:

Global Swine Healthcare market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Swine Healthcare Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Type (Diagnostics, Therapeutics)
- 5.2.2. By Disease (Exudative dermatitis (greasy pig disease), Coccidiosis, Respiratory Diseases, Swine Dysentery, Porcine Parvovirus, Other)
- 5.2.3. By Company (2023)
- 5.2.4. By Region
5.3. Market Map

6. North America Swine Healthcare Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By Disease
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Swine Healthcare Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Type
    - 6.3.1.2.2. By Disease
- 6.3.2. Mexico Swine Healthcare Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Type
    - 6.3.2.2.2. By Disease
- 6.3.3. Canada Swine Healthcare Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Type
    - 6.3.3.2.2. By Disease

7. Europe Swine Healthcare Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Disease
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. France Swine Healthcare Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Type
    - 7.3.1.2.2. By Disease
- 7.3.2. Germany Swine Healthcare Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Type
    - 7.3.2.2.2. By Disease
- 7.3.3. United Kingdom Swine Healthcare Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Type
    - 7.3.3.2.2. By Disease
- 7.3.4. Italy Swine Healthcare Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Type
    - 7.3.4.2.2. By Disease
- 7.3.5. Spain Swine Healthcare Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Type
    - 7.3.5.2.2. By Disease

8. Asia-Pacific Swine Healthcare Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Disease
- 8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Swine Healthcare Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Type
    - 8.3.1.2.2. By Disease
- 8.3.2. India Swine Healthcare Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Type
    - 8.3.2.2.2. By Disease
- 8.3.3. South Korea Swine Healthcare Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Type
    - 8.3.3.2.2. By Disease
- 8.3.4. Japan Swine Healthcare Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Type
    - 8.3.4.2.2. By Disease
- 8.3.5. Australia Swine Healthcare Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Type
    - 8.3.5.2.2. By Disease

9. South America Swine Healthcare Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Disease
- 9.2.3. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Swine Healthcare Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Type
    - 9.3.1.2.2. By Disease
- 9.3.2. Argentina Swine Healthcare Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Type
    - 9.3.2.2.2. By Disease
- 9.3.3. Colombia Swine Healthcare Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Type
    - 9.3.3.2.2. By Disease

10. Middle East and Africa Swine Healthcare Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Disease
- 10.2.3. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Swine Healthcare Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Type
    - 10.3.1.2.2. By Disease
- 10.3.2. Saudi Arabia Swine Healthcare Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Type
    - 10.3.2.2.2. By Disease
- 10.3.3. UAE Swine Healthcare Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Type
    - 10.3.3.2.2. By Disease

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Porters Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products

14. Competitive Landscape

14.1. Boehringer Ingelheim International GmbH
- 14.1.1. Business Overview
- 14.1.2. Company Snapshot
- 14.1.3. Products & Services
- 14.1.4. Financials (As Reported)
- 14.1.5. Recent Developments
- 14.1.6. Key Personnel Details
- 14.1.7. SWOT Analysis
14.2. Ceva Sante Animale
14.3. Elanco Animal Health Incorporated
14.4. Innovative Diagnostics
14.5. Merck KgaA
14.6. Vetoquinol SA
14.7. Virbac S.A.
14.8. Zoetis Inc.
14.9. IDEXX Laboratories, Inc
14.10. Phibro Animal Health Corporation